---
figid: PMC11484340__ol-28-06-14719-g02
figtitle: Cross-inhibition between the PI3K/AKT/mTOR and RAF/MEK/ERK pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11484340
filename: ol-28-06-14719-g02.jpg
figlink: /pmc/articles/PMC11484340/figure/F3/
number: F3
caption: Cross-inhibition between the PI3K/AKT/mTOR and RAF/MEK/ERK pathways. AKT
  negatively regulates ERK activation by phosphorylating and inactivating RAF, while
  MEK suppresses the PI3K signaling pathway by promoting the membrane localization
  of PTEN, thereby achieving the negative regulation between the two pathways. PI3K,
  phosphatidylinositol-3 kinase; AKT, protein kinase B; mTOR, mammalian target of
  rapamycin; RAF, rapidly accelerated fibrosarcoma; MEK, mitogen-activated protein
  kinase kinase; ERK, extracellular signal-regulated kinase; PTEN, phosphatase and
  tensin homologue
papertitle: 'Steroidal saponins: Natural compounds with the potential to reverse tumor
  drug resistance (Review)'
reftext: Aiping Cui, et al. Oncol Lett. 2024 Dec;28(6).
year: '2024'
doi: 10.3892/ol.2024.14719
journal_title: Oncology Letters
journal_nlm_ta: Oncol Lett
publisher_name: Spandidos Publications
keywords: steroidal saponins | chemotherapy | drug resistance | antitumor effect |
  mechanism
automl_pathway: 0.9499183
figid_alias: PMC11484340__F3
figtype: Figure
redirect_from: /figures/PMC11484340__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11484340__ol-28-06-14719-g02.html
  '@type': Dataset
  description: Cross-inhibition between the PI3K/AKT/mTOR and RAF/MEK/ERK pathways.
    AKT negatively regulates ERK activation by phosphorylating and inactivating RAF,
    while MEK suppresses the PI3K signaling pathway by promoting the membrane localization
    of PTEN, thereby achieving the negative regulation between the two pathways. PI3K,
    phosphatidylinositol-3 kinase; AKT, protein kinase B; mTOR, mammalian target of
    rapamycin; RAF, rapidly accelerated fibrosarcoma; MEK, mitogen-activated protein
    kinase kinase; ERK, extracellular signal-regulated kinase; PTEN, phosphatase and
    tensin homologue
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - PDK1
  - PDPK1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TSC1
  - CCL26
  - TSC2
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - GSK3A
  - GSK3B
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - MDM2
  - BAD
  - EPHB2
  - MAPK1
  - MAPK3
  - RPTOR
  - MYC
  - FASLG
  - BCL2L11
  - TP53
  - TP63
  - TP73
  - RAS
  - MEK
  - BIM
  - Cancer
---
